🇺🇸 US Historic Schedule III Push Reshapes Market Between Federal Medical Recognition And Hemp Crackdowns
🇩🇪 Germany Tightens Medical Access As €3.7bn Cannabis Industry And 143‑Tonne Imports Keep Growing
🇨🇦 Canadian Exports Jump 124% As Domestic Sales Plateau And BC Strike Cuts Revenue
🇦🇺 Australia Tightens Compliance As Pastille Approvals Surge
🇮🇱 Israel imports 27 tonnes in 2025 as Court Scraps 165% Tariff on Canadian cannabis
🇬🇧 UK’s Private Cannabis Prescriptions Jump 262% As Novel Foods Bottleneck Distorts Legal Access
🇳🇱 Netherlands’ Logs €57.5m CanAdelaar Deal And Record 60‑Tonne Cannabis Seizures
🇵🇱 Poland’s 537,000 Prescriptions and 5 Tonnes Sold in 2025 Mark Europe’s Fastest‑Formalising Flower Market
🇧🇷 Brazil’s ANVISA Freeze Stalls Oil Market Just As Use Jumps Past 15% And Science Demands A New Framework
🇳🇿 New Zealand’s Hemp Deregulation and a 1% THC Line Reset the Playing Field for Food, Fibre and Wellness
🇨🇠Switzerland’s Cautious Pilot Projects and 30% Pharmacy Price Gaps Highlight Uneven Access Despite Legal THC Trials
🇫🇷 France's Extended 3,000‑Patient Pilot and €500 Fines Expose the Cost of Delayed Medical Roll‑Out
🇪🇸 Spain’s Pharmacists Take Medical Cannabis Decree To The Supreme Court
🇵🇹 Portugal’s Raids, Licence Reinstatements and Alleged €1.60/g Dumping Undermine Its Image as a Medical Export Hub
🇮🇹 Italy’s Hemp Sector Waits On Constitutional Court As Government Balances Flower Bans Against A 40% ‘Cannabis Light’ Model
🇲🇦 Morocco's ANRAC Halves Licences as Cannaflex Turns Historic Hash Heartland into Finished‑Dose Export Platform
🇦🇷 Argentina’s provincial Rules and CONICET‑Backed Trials Turn Medicinal Cannabis into a Federally Fractured Lab
🇲🇽 Mexico’s CBD Import Licences and a US$60m Paradise Sale Prefigure Consolidation Before Full Legalisation Arrives
🇪🇺 EU Puts Hemp At The Centre Of Its Bioeconomy While Drug Strategy Still Privileges Policing Over Regulated Cannabis Access
🇿🇦 South Africa’s 2% THC Hemp, SAPS Permits and ‘Project Indlela’ Struggle to Pull Legacy Growers into the Legal Fold